Libya vs Thailand: Cause of death, by non-communicable diseases, ages 0-4, male
Libya
41.5%
in 2021
Thailand
41.1%
in 2021
Libya rank
36th
Thailand rank
38th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Libya
- Thailand
How they compare
Libya currently reports 41.5% against 41.1% in Thailand, a difference of 0.4%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Libya ahead.
Libya ranks 36th and Thailand ranks 38th of 185 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.3% | 25.6% | 2.7% | Libya |
| 2010s | 38.9% | 38.2% | 0.7% | Libya |
| 2020s | 41.3% | 41.2% | 0.1% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Libya or Thailand?
- Libya, at 41.5% against 41.1% in Thailand as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Libya and Thailand?
- 0.4%, with Libya ahead.
- How many years of comparable data are there for Libya and Thailand?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Thailand rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Libya ranks 36th and Thailand ranks 38th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.